AETHLON MEDICAL INC AEMD
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus
Chart by TradingView
3/9
Piotroski F — financial health
-90.06
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2026 | — | -$7.2M | — | -$7.0M | $4.9M |
| 2025 | — | -$13.4M | — | -$7.6M | $5.1M |
| 2024 | $0 | -$12.2M | — | -$10.4M | $5.8M |
| 2023 | $574,245 | -$12.0M | — | -$11.4M | $15.1M |
| 2022 | $294,165 | -$10.4M | — | -$10.1M | $17.0M |
| 2021 | $659,104 | -$7.9M | — | -$6.8M | $9.3M |
Why these scores methodology →
Piotroski F-score: 3/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -90.06 (distress)
- Working capital / assets 0.651
- Retained earnings / assets -27.649
- EBIT / assets -1.152
- Equity / liabilities 3.377
Source: SEC EDGAR filings · CIK 0000882291 · as of 2026-03-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.